CORPORATE PRESENTATION
We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.
Quarterly Results
Press Releases
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and full year 2025 financial results before...
This study was the world’s first FDA-cleared clinical trial using a bioengineered liver. Based on these positive results, United Therapeutics will initiate a phase 2 studyApproximately 30% of acute liver failure patients...
22 Jan 2026
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
SILVER SPRING, Md. & DURHAM, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors appointed Kevin J. Tracey, M.D....
05 Jan 2026
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
SILVER SPRING, Md. & DURHAM, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that company executives will provide an overview and...
Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal DiseaseSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq:...
Events and presentations
25 Feb 2026
United Therapeutics Fourth Quarter and Full Year 2025 Financial Results
09:00 AM ET
12 Jan 2026
44th Annual J.P. Morgan Healthcare Conference
04:30 PM ET
18 Nov 2025
Jefferies Global Healthcare Conference
07:00 AM ET
10 Nov 2025
UBS Global Healthcare Conference
09:30 AM ET
29 Oct 2025
United Therapeutics Third Quarter 2025 Financial Results
09:00 AM ET
28 Sep 2025
Phase 3 TETON-2 Results Conference Call
12:30 PM ET